Several studies identified the frequently altered genes in SCLC (35, 36) (Table 3), and gene losses and mutations, including the deletion of TP53 and RB1 and amplification of SOX2 and MYC in SCLC, lead to the high tumor mutation burden (TMB) in SCLC (37). This evidence concerns the gene RB1 and small cell lung carcinoma.